Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Lung Cancer Patients

Histone deacetylase inhibitor (HDACi, vorinostat) responses were studied in murine and human lung cancer cell lines and genetically-engineered mouse lung cancer models. Findings were compared with a window of opportunity trial in aerodigestive tract cancers. In human (HOP62, H522 and H23) and murine...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Ma, Tian, Galimberti, Fabrizio, Erkmen, Cherie P., Memoli, Vincent, Chinyengetere, Fadzai, Sempere, Lorenzo, Beumer, Jan H., Anyang, Bean N., Nugent, William, Johnstone, David, Tsongalis, Gregory J., Kurie, Jonathan M., Li, Hua, DiRenzo, James, Guo, Yongli, Freemantle, Sarah J., Dragnev, Konstantin H., Dmitrovsky, Ethan
Format: Artigo
Język:Inglês
Wydane: 2013
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742691/
https://ncbi.nlm.nih.gov/pubmed/23686769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0933
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy